These data are consistent with results obtained by Selimovic et al., which revealed significantly higher levels of IL-6, transforming growth factor β1 (TGFβ1), platelet-derived growth factor (PDGF), and vascular endothelial growth factor (VEGF) in PAH patients compared to controls. The gene discussed is VEGFA; the disease is pulmonary arterial hypertension.